Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-26Clinical Trial Update: Minimally Invasive Versus Conventional Approaches in Navigated Total Knee Arthroplasty (TKA) [Phase 4]
Phase 4 clinical trial comparing minimally invasive versus conventional navigated total knee arthroplasty was terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA) [Phase 2]
A Phase 2 clinical trial of AK106-001616 in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA) [Phase 2]
A Phase 2 trial of AK106-001616 in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: A Study of Tocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis. [Phase 3]
A Phase 3 trial evaluating tocilizumab in combination with DMARDs in active rheumatoid arthritis has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Safety, Tolerability, PK, PD, and Immunogenicity of Single and Multiple Ascending Intravenous Doses of FR104 [Phase 1]
Phase 1 study of FR104 (intravenous) in rheumatoid arthritis and transplant complications assessing safety, tolerability, PK/PD, and immunog…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents. [Phase 3]
Phase 3 trial assessing secukinumab in rheumatoid arthritis patients with inadequate response to anti-TNF therapy. The study was terminated …
-
CLINICAL_TRIALS research · 2016-07-21Clinical Trial Update: Observational Study of Tocilizumab in Participants With Rheumatoid Arthritis in Australia
An observational study of tocilizumab in Australian patients with rheumatoid arthritis has completed, with results posted in July 2016.
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity [Phase 4]
Phase 4 study assessing the efficacy and safety of buprenorphine transdermal patch in adults with moderate non-cancer pain, including osteoa…
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002) [Phase 1]
Phase 1 study update on the pharmacokinetics and safety of MK-8808 (MK-8808-002) in rheumatoid arthritis. The trial was terminated, and resu…
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3) [Phase 2]
A Phase 2 study (Taski-3) evaluating the efficacy and safety of R935788 tablets in rheumatoid arthritis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Gamma Vacuum Foil (GVF) Versus Cross-linked Polyethylene in Total Knee Arthroplasty Study [NA]
This clinical trial compared Gamma Vacuum Foil (GVF) versus cross-linked polyethylene in total knee arthroplasty, with results posted after …
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: A Study of Tocilizumab and Methotrexate in Combination or as Monotherapy in Treatment-Naïve Patients With Early Rheumatoid Arthritis [Phase 3]
Phase 3 trial results evaluating tocilizumab with methotrexate versus monotherapy in treatment-naïve patients with early rheumatoid arthriti…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab [Phase 4]
Phase 4 trial evaluating etanercept in rheumatoid arthritis patients who lost response to adalimumab; study terminated with results posted i…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening [Phase 4]
A Phase 4 clinical trial update in rheumatoid arthritis patients with moderate to severe disease activity despite methotrexate (with or with…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis
This clinical trial update reports the efficacy and safety results of tocilizumab (RoActemra) in participants with rheumatoid arthritis.
-
FDA approval · 2016-06-30FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) to Cordavis Limited, authorizing the continued manufacturing/supply of the p…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patients
This update summarizes long-term outcomes for rheumatoid arthritis patients who demonstrated an early response to certolizumab pegol (Cimzia…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Efficacy Study of FANG(30) for Active Rheumatoid Arthritis in Adult Patients [Phase 2]
A Phase 2 efficacy trial of FANG(30) in adults with active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: A Study of MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy. [Phase 3]
Phase 3 clinical trial update of Rituximab (MabThera) in rheumatoid arthritis patients with inadequate response to DMARDs and/or anti-TNF th…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: An Observational Study of the Impact of RoActemra/Actemra on Fatigue in Patients With Rheumatoid Arthritis (PEPS)
This is a completed observational study evaluating the impact of RoActemra/Actemra on fatigue in patients with rheumatoid arthritis, with re…
-
CLINICAL_TRIALS research · 2016-06-21Clinical Trial Update: Gum Arabic as Immunomodulator In Rheumatoid Arthritis Patients [Phase 2]
A Phase 2 clinical trial is evaluating gum arabic as an immunomodulator for rheumatoid arthritis; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: CARNet : Self-Monitoring and Co-driving in Rheumatology With Internet : Rheumatoid Arthritis Cohort (Usual Care Study) [NA]
A clinical trial evaluating self-monitoring and internet-assisted management in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS research · 2016-06-20Clinical Trial Update: Efficacy and Safety of Traditional Chinese Medicine (TCM) Comprehensive Therapy in Patients With Rheumatoid Arthritis [Phase 2, Phase 3]
A clinical trial update on the efficacy and safety of Traditional Chinese Medicine Comprehensive Therapy for rheumatoid arthritis in Phase 2…
-
CLINICAL_TRIALS trial_result · 2016-06-16Clinical Trial Update: A Phase II, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Natalizumab in Subjects With Rheumatoid Arthritis Who Have Previously Participated in Study ELN100226-RA201 [Phase 2]
This document provides a Phase II open-label update on the long-term safety, tolerability, and efficacy of intravenous natalizumab in rheuma…
-
CLINICAL_TRIALS trial_result · 2016-06-13Clinical Trial Update: Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis [Phase 2]
Reports the completion of a Phase 2 efficacy and safety trial of R935788 tablets for rheumatoid arthritis, with results posted in 2016.